Back

Determinants of CA125 elevation and the comparative prognostic value of the NTproBNP/CA125 ratio in heart failure

9 May 2026 (10:47 - 11:55)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - biomarkers (2) Biomarkers Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Damien Gruson

Cliniques Saint-Luc UCL, Brussels (Belgium)

6 More presentations in this session

Presentation thumbnail
Circulating biomarkers and proteomic profile changes in elderly patients with heart failure with improved ejection fraction: a real-life study
Doctor V. Cassano (Catanzaro, IT)
Abstract Slides
Presentation thumbnail
Analytical verification, usability, and clinical suitability of a whole-blood point of care NTproBNP assay for rapid heart failure assessment
Professor D. Gruson (Brussels, BE)
Abstract Slides
Presentation thumbnail
Proteomic signatures of atrial fibrillation in hospitalized patients with heart failure
Doctor Z. Nezami (Malmo, SE)
Abstract Slides
Presentation thumbnail
NT-proBNP assessment during hospitalisation for acute heart failure: a real-world study
Doctor I. Cruz (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Laboratory biomarkers of poor prognosis in patients admitted for acute heart failure
Doctor I. Cruz (Coimbra, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - biomarkers (2)

The Event

Event poster

Heart Failure 2026

9 May 2026 10:47 CET
You may be interested in
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Presentation
A proteo-genomic discovery approach to identify markers of early heart failure
thumbnail
Congress Presentation
State-of-the-art lecture on current state of the diagnosis of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources